Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Clinical Laserthermia Systems AB
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Cytohistological diagnosis of ductal pancreatic adenocarcinoma .
Stage III disease (see above).
The patient is not a candidate for continued chemotherapy or (chemo)radiotherapy due to lack of demonstrable efficiency or to the side effects of the drugs.
Age between 18 and 80 years.
Anticipated compliance with treatment and follow-up.
Double informed consent for both imILT and possible surgery with radical intent (in the event of pre-operative overstaging).
At least a part of the tumor can be treated with imILT without damage to surrounding vital structures.
Have an ECOG performance status \< 1 (l'Eastern Cooperative Oncology Group)
You may not be if
Not a candidate for laparotomy.
Becoming resectable after neoadjuvant chemotherapy.
Other simultaneous treatments for the same neoplasm.
Simultaneous other malignancies except for basal cell carcinoma.
HIV positive.
Active autoimmune disease.
Systemic corticosteroid medication.
Pregnancy or nursing.
Clareo Health | Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
